Accredited Section 3
Accreditation Period: 20 July 2026 - 19 July 2029

Hypoxemia is an important complication of general anesthesia and procedural sedation and is associated with cardiopulmonary complications, increased hospital length of stay, and increased mortality. Through this Continuing Professional Development module, we aim to guide anesthesiologists in the safe use of high-flow nasal oxygen (HFNO). It examines the potential advantages and limitations of HFNO across the spectrum of anesthesiology practice, from procedural sedation to airway management, highlighting its role in enhancing patient safety.

After reading this module, the reader should be able to:
1. Show an understanding of high-flow nasal oxygen physiology.
2. Evaluate the current literature supporting the use of high-flow nasal oxygen in anesthesiology practice.
3. Recognize the clinical applications, limitations, and risks of high-flow nasal oxygen in patients requiring anesthesia care.
4. Integrate high-flow nasal oxygen therapy into the anesthesia management of appropriately selected patients and procedures.